{
    "info": {
        "nct_id": "NCT05417932",
        "official_title": "A Phase 1/ 2a, Multicenter Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma",
        "inclusion_criteria": "* Histologically or cytologically confirmed Hepatocellular carcinoma (HCC)\n* Subjects with HCC who have received at least 2 standard systemic therapies\n* HLA-A *02\n* BCLC stage B or C\n* Child-pugh score ≤ 7\n* Serum HBeAg negative, serum (or tumor tissue) HBsAg positive, and serum HBV-DNA must be 2 × 1000 IU/ml\n* Have at least one measurable leasion at baseline as per mRECIST and RECIST v1.1 criteria\n* Life expectancy of 3 months or greater\n* Ability to provide informed consent form\n* Ability to comply with all the study procedures\n\nMain\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
        "exclusion_criteria": "* Subjects with history of another primary cancer\n* Untreated or active central nervous system (CNS) or leptomeningeal metastasis, or history of hepatic encephalopathy, or other clinically significant CNS diseases\n* Autoimmune diseases requiring immunosuppressive therapy (except topical medication) or subjects with significant persistent immune rejection\n* Known history of neurological or mental disorder, including epilepsy or dementia\n* Known history of positive results for human immunodeficiency virus (HIV) 1 or 2 or known acquired immunodeficiency syndrome (AIDS)\n* Prior exposure to any cell therapy such as, but not limited to killer (NK) cells, cytokine-induced killer (CIK) cells, dendritic cells (DC), cytotoxic T lymphocytes (CTL), stem cell therapy, CAR T/TCR T cell therapy\n* Allergy to immunotherapy drugs and lymphodepleting chemotherapy (cyclophosphamide and fludarabine)\n* Any subjects who cannot be evaluated by either triphasic liver CT or triphasic MRI because of allergy or other contraindication to both CT and MRI contrast agents\n* Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation",
        "miscellaneous_criteria": "Main"
    },
    "inclusion_lines": [
        {
            "line": "* Have at least one measurable leasion at baseline as per mRECIST and RECIST v1.1 criteria",
            "criterions": [
                {
                    "exact_snippets": "at least one measurable leasion at baseline as per mRECIST and RECIST v1.1 criteria",
                    "criterion": "measurable lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": [
                                "mRECIST",
                                "RECIST v1.1"
                            ]
                        },
                        {
                            "requirement_type": "timepoint",
                            "expected_value": "baseline"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Main",
            "criterions": [
                {
                    "exact_snippets": "Main",
                    "criterion": "main criterion",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "Main"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to provide informed consent form",
            "criterions": [
                {
                    "exact_snippets": "Ability to provide informed consent form",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability to provide",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Child-pugh score ≤ 7",
            "criterions": [
                {
                    "exact_snippets": "Child-pugh score ≤ 7",
                    "criterion": "Child-Pugh score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 70 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 70 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 70,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* BCLC stage B or C",
            "criterions": [
                {
                    "exact_snippets": "BCLC stage B or C",
                    "criterion": "BCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "B",
                                "C"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with HCC who have received at least 2 standard systemic therapies",
            "criterions": [
                {
                    "exact_snippets": "Subjects with HCC",
                    "criterion": "hepatocellular carcinoma (HCC) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "have received at least 2 standard systemic therapies",
                    "criterion": "number of standard systemic therapies received",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "standard systemic therapies"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* HLA-A *02",
            "criterions": [
                {
                    "exact_snippets": "HLA-A *02",
                    "criterion": "HLA-A*02 allele",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to comply with all the study procedures",
            "criterions": [
                {
                    "exact_snippets": "Ability to comply with all the study procedures",
                    "criterion": "ability to comply with study procedures",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of 3 months or greater",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of 3 months or greater",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum HBeAg negative, serum (or tumor tissue) HBsAg positive, and serum HBV-DNA must be 2 × 1000 IU/ml",
            "criterions": [
                {
                    "exact_snippets": "Serum HBeAg negative",
                    "criterion": "serum HBeAg",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "serum (or tumor tissue) HBsAg positive",
                    "criterion": "HBsAg",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serum HBV-DNA must be 2 × 1000 IU/ml",
                    "criterion": "serum HBV-DNA",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "=",
                                "value": 2000,
                                "unit": "IU/ml"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically or cytologically confirmed Hepatocellular carcinoma (HCC)",
            "criterions": [
                {
                    "exact_snippets": "Histologically or cytologically confirmed Hepatocellular carcinoma (HCC)",
                    "criterion": "Hepatocellular carcinoma (HCC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Allergy to immunotherapy drugs and lymphodepleting chemotherapy (cyclophosphamide and fludarabine)",
            "criterions": [
                {
                    "exact_snippets": "Allergy to immunotherapy drugs",
                    "criterion": "allergy to immunotherapy drugs",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Allergy to ... lymphodepleting chemotherapy (cyclophosphamide and fludarabine)",
                    "criterion": "allergy to lymphodepleting chemotherapy (cyclophosphamide and fludarabine)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history of positive results for human immunodeficiency virus (HIV) 1 or 2 or known acquired immunodeficiency syndrome (AIDS)",
            "criterions": [
                {
                    "exact_snippets": "Known history of positive results for human immunodeficiency virus (HIV) 1 or 2",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "history of positive result",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known acquired immunodeficiency syndrome (AIDS)",
                    "criterion": "AIDS",
                    "requirements": [
                        {
                            "requirement_type": "history of diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior exposure to any cell therapy such as, but not limited to killer (NK) cells, cytokine-induced killer (CIK) cells, dendritic cells (DC), cytotoxic T lymphocytes (CTL), stem cell therapy, CAR T/TCR T cell therapy",
            "criterions": [
                {
                    "exact_snippets": "Prior exposure to any cell therapy such as, but not limited to killer (NK) cells, cytokine-induced killer (CIK) cells, dendritic cells (DC), cytotoxic T lymphocytes (CTL), stem cell therapy, CAR T/TCR T cell therapy",
                    "criterion": "prior exposure to cell therapy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "cell therapy types",
                            "expected_value": [
                                "killer (NK) cells",
                                "cytokine-induced killer (CIK) cells",
                                "dendritic cells (DC)",
                                "cytotoxic T lymphocytes (CTL)",
                                "stem cell therapy",
                                "CAR T/TCR T cell therapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Autoimmune diseases requiring immunosuppressive therapy (except topical medication) or subjects with significant persistent immune rejection",
            "criterions": [
                {
                    "exact_snippets": "Autoimmune diseases requiring immunosuppressive therapy (except topical medication)",
                    "criterion": "autoimmune diseases",
                    "requirements": [
                        {
                            "requirement_type": "immunosuppressive therapy requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "immunosuppressive therapy type",
                            "expected_value": {
                                "operator": "!=",
                                "value": 1,
                                "unit": "topical medication"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "subjects with significant persistent immune rejection",
                    "criterion": "immune rejection",
                    "requirements": [
                        {
                            "requirement_type": "persistence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history of neurological or mental disorder, including epilepsy or dementia",
            "criterions": [
                {
                    "exact_snippets": "Known history of neurological or mental disorder",
                    "criterion": "neurological or mental disorder",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including epilepsy",
                    "criterion": "epilepsy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... dementia",
                    "criterion": "dementia",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Untreated or active central nervous system (CNS) or leptomeningeal metastasis, or history of hepatic encephalopathy, or other clinically significant CNS diseases",
            "criterions": [
                {
                    "exact_snippets": "Untreated or active central nervous system (CNS) or leptomeningeal metastasis",
                    "criterion": "central nervous system (CNS) or leptomeningeal metastasis",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        },
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "history of hepatic encephalopathy",
                    "criterion": "hepatic encephalopathy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other clinically significant CNS diseases",
                    "criterion": "clinically significant CNS diseases",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any subjects who cannot be evaluated by either triphasic liver CT or triphasic MRI because of allergy or other contraindication to both CT and MRI contrast agents",
            "criterions": [
                {
                    "exact_snippets": "cannot be evaluated by either triphasic liver CT or triphasic MRI because of allergy or other contraindication to both CT and MRI contrast agents",
                    "criterion": "ability to be evaluated by triphasic liver CT or triphasic MRI",
                    "requirements": [
                        {
                            "requirement_type": "evaluability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "allergy or other contraindication to both CT and MRI contrast agents",
                    "criterion": "allergy or contraindication to CT and MRI contrast agents",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation",
            "criterions": [
                {
                    "exact_snippets": "Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation",
                    "criterion": "any condition making subject unsuitable for trial participation",
                    "requirements": [
                        {
                            "requirement_type": "investigator's opinion of suitability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with history of another primary cancer",
            "criterions": [
                {
                    "exact_snippets": "history of another primary cancer",
                    "criterion": "history of another primary cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Main",
            "criterions": [
                {
                    "exact_snippets": "Main",
                    "criterion": "main criterion",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "Main"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}